Clinical investigations for SUS, the Brazilian public health system

Authors

  • Ana Patrícia de Paula Ministry of Health
  • Silvana Pereira Giozza Ministry of Health
  • Michelle Zanon Pereira Ministry of Health
  • Patrícia Souza Boaventura Ministry of Health
  • Leonor Maria Pacheco Santos Ministry of Health
  • Camile Giaretta Sachetti Ministry of Health
  • César Omar Carranza Tamayo Ministry of Health
  • Clarissa Campos Guaragna Kowalski Ministry of Health
  • Flavia Tavares Silva Elias Ministry of Health
  • Suzanne Jacob Serruya Ministry of Health
  • Reinaldo Guimarães Ministry of Health

Keywords:

Biomedical research, Technology assessment, biomedical, Health policy, Health services research, Public health

Abstract

CONTEXT AND OBJECTIVE: Scientific and technological development is crucial for advancing the Brazilian health system and for promoting quality of life. The way in which the Brazilian Ministry of Health has supported clinical research to provide autonomy, self-sufficiency, competitiveness and innovation for the healthcare industrial production complex, in accordance with the National Policy on Science, Technology and Innovation in Healthcare, was analyzed. DESIGN AND SETTING: Descriptive investigation, based on secondary data, conducted at the Department of Science and Technology, Ministry of Health. METHODS: The Ministry of Health’s research management database, PesquisaSaúde, was analyzed from 2002 to 2009, using the key word “clinical research” in the fields “primary sub-agenda” or “secondary subagenda”. The 368 projects retrieved were sorted into six categories: basic biomedical research, preclinical studies, expanded clinical research, clinical trials, infrastructure support and health technology assessment. From a structured review on “clinical research funding”, results from selected countries are presented and discussed. RESULTS: The amount invested was R$ 140 million. The largest number of projects supported “basic biomedical research”, while the highest amounts invested were in “clinical trials” and “infrastructure support”. The southeastern region had the greatest proportion of projects and financial resources. In some respects, Brazil is ahead of other BRICS countries (Russia, India, China and South Africa), especially with regard to establishing a National Clinical Research Network. CONCLUSION: The Ministry of Health ensured investments to encourage clinical research in Brazil and contributed towards promoting cohesion between investigators, health policies and the healthcare industrial production complex.

Downloads

Download data is not yet available.

Author Biographies

Ana Patrícia de Paula, Ministry of Health

MD, PhD. Coordinator, Postgraduate Program, Escola Superior de Ciências da Saúde, Fundação de Ensino e Pesquisa em Ciências da Saúde, Federal District Health Department, Brasília, Federal District, Brazil.

Silvana Pereira Giozza, Ministry of Health

DDS, PhD. Consultant, Department of Science and Technology, Ministry of Health, Brasília, Federal District, Brazil.

Michelle Zanon Pereira, Ministry of Health

MSc. Consultant Nutritionist, Department of Science and Technology, Ministry of Health, Brasília, Federal District, Brazil.

Patrícia Souza Boaventura, Ministry of Health

Consultant Specialist Pharmacist, Department of Science and Technology, Ministry of Health, Brasília, Federal District, Brazil.

Leonor Maria Pacheco Santos, Ministry of Health

PhD. Chemist and Professor, Department of Public Health, Universidade de Brasília (UnB), Brasília, Federal District, Brazil.

Camile Giaretta Sachetti, Ministry of Health

MSc. Consultant Pharmacist, Department of Science and Technology, Ministry of Health, Brasília, Federal District, Brazil.

César Omar Carranza Tamayo, Ministry of Health

MD, PhD. Consultant, Department of Science and Technology, Ministry of Health, Brasília, Federal District, Brazil.

Clarissa Campos Guaragna Kowalski, Ministry of Health

DDS, MSc. Consultant, Department of Science and Technology, Ministry of Health, Brasília, Federal District, Brazil.

Flavia Tavares Silva Elias, Ministry of Health

MSc.Nutritionist, General Coordinator, Department of Science and Technology, Ministry of Health, Brasília, Federal District, Brazil.

Suzanne Jacob Serruya, Ministry of Health

MD, PhD. Consultant, Latin American Centre for Perinatology and Women and Reproductive Health, Pan-American Health Organization, Montevideo, Uruguay.

Reinaldo Guimarães, Ministry of Health

MD, MSc. Professor, Universidade Estadual do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.

References

Brasil. Presidência da República. Casa Civil. Subchefia para Assuntos Jurídicos. Constituição da República Federativa do Brasil de 1988. Available from: http://www.planalto.gov.br/ccivil_03/Constituicao/Constituicao.htm. Accessed in 2011 (Oct 22).

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Decit 10 anos. Brasília: Ministério da Saúde; 2010. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/decit_10anos.pdf. Accessed in 2011 (Oct 22).

Guimarães R, Santos LMP, Angulo-Tuesta A, Serruya SJ. Defining and implementing a National Policy for Science, Technology, and Innovation in Health: lessons from the Brazilian experience. Cad Saúde Pública = Rep Public Health. 2006;22(9):1775-85.

Brazil. Ministry of Health. Secretariat of Science, Technology and Strategic Inputs. Department of Science and Technology. National Agenda of Priorities in Health Research - Brazil. Brasília: Ministério da Saúde; 2006. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/agenda_ingles.pdf. Accessed in 2011 (Oct 22).

Ministério da Saúde. Rede Nacional de Pesquisa Clínica do Brasil: respostas e redução da dependência estrangeira [National clinical research network: Brazilian response and mitigation of international dependency]. Rev Saúde Pública = J Public Health. 2010;44(3):575-8.

Brasil. Ministério da Saúde. Conselho Nacional de Saúde. 2a Conferência Nacional de Ciência, Tecnologia e Inovação em Saúde, Brasília, 25 a 28 de julho de 2004. Brasília: Ministério da Saúde; 2004. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/2CNCTISfinal.pdf. Accessed in 2011 (Oct 22).

Association of American Medical Colleges Task Force on Clinical Research 2000. Washington: Association of American Medical Colleges; 1999.

Agência Européia para Avaliação de Produtos Medicinais. Unidade de Avaliação de Medicamentos Humanos. Manual para a Boa Prática Clínica. Versão harmonizada tripartite (USA, Europa e Japão) elaborada pela Conferência Internacional de Harmonização (ICH). Available from: www.ufrgs.br/bioetica/gcpport.htm. Accessed in 2011 (Oct 11).

Marzochi KBF. Pesquisa clínica ampliada: conceito e prática. Available from: http://www.fiocruz.br/pesquisaclinica/media/Pesquisaclinica Ampliada -Keyla.pdf. Accessed in 2011 (Oct 28).

Brasil. Ministério da Saúde. Departamento de Ciência e Tecnologia. Pesquisa Saúde. Departamento de Ciência e Tecnologia (Decit/ SCTIE/MS). Available from: http://www.saude.gov.br/pesquisasaude. Accessed in 2011 (Oct 28).

Organização para a Cooperação e Desenvolvimento Econômico. Frascati Manual. Paris: OCDE; 1993.

Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Medicamentos. Considerações e definições para Pesquisa Clínica. Available from: http://www.anvisa.gov.br/medicamentos/pesquisa/def.htm. Accessed in 2011 (Oct 11).

Quental C, Salles Filho S. Ensaios clínicos: capacitação nacional para avaliação de medicamentos e vacinas [Clinical Trials: Brazilian capability to evaluate drugs and vaccines]. Rev Bras Epidemiol. 2006;9(4):408-24.

Brasil. Conselho Nacional de Saúde. Resolução no 251, de 07 de agosto de 1997. Aprova as normas de pesquisa envolvendo seres humanos para a área temática de pesquisa com novos fármacos, medicamentos, vacinas e testes diagnósticos. Available from: http://www.datasus.gov.br/conselho/resol97/res25197.htm. Accessed in 2011 (Oct 22).

Zago MA. A pesquisa clínica no Brasil [Clinical research in Brazil]. Ciênc Saúde Coletiva. 2004;9(2):363-74.

World Health Organization. Neglected tropical diseases. Frequently asked questions. Available from: http://www.who.int/neglected_diseases/faq/en/index5.html. Accessed in 2011 (Oct 22).

Caramori CA, Barraviera B. Universities and neglected diseases: it is not enough to have the knowledge, it must be applied. J Venom Anim Toxins Incl Trop Dis. 2011;17(1):1-3.

Machado PR, Ampuero J, Guimarães LH, et al. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial. PLoS Negl Trop Dis. 2010;4(12):e912.

Costa GC, da Costa Rocha MO, Moreira PR, et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis. 2009;199(3):451-4.

Gomes FS, Spínola C de V, Ribeiro HA, et al. Wound-healing activity of a proteolytic fraction from Carica candamarcensis on experimentally induced burn. Burns. 2010;36(2):277-83.

Pacheco S. Pesquisadores brasileiros criam exame molecular que reduz de oito para quatro horas o diagnóstico da gripe A. Correio Brasiliense, 26/06/2010. Availablefrom: http://www.correiobraziliense.com.br/app/noticia/ciencia-e-saude/2010/06/26/interna_ciencia_saude,199542/index.shtml. Accessed in 2011 (Oct 11).

Gillum LA, Gouveia C, Dorsey ER, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6(2):e16837.

Rothwell PM. Funding for practice-oriented clinical research. Lancet. 2006;368(9532):262-6.

Rawlins M. A new era for UK clinical research? Lancet. 2011;377(9761):190-2.

Reihart D, Platonov P. Clinical trials in Russia: growing experience and revision of regulations. International Journal of Pharmaceutical Medicine. 2005;19(2):73-6. Available from: http://www.ingentaconnect.com/content/adis/ipm/2005/00000019/00000002/art00002. Accessed in 2011 (Nov 4).

Vlassov V. Russian clinical research is threatened by ban on export of samples. BMJ. 2007;334(7606):1237.

World Health Organization. News. Clinical trials in India: ethical concerns. Bulletin of the World Health Organization. 2008;86(8):581-2. Available from: http://www.who.int/bulletin/volumes/86/8/08-010808.pdf. Accessed in 2011 (Nov 4).

Srinivasan S. Ethical concerns in clinical trials in India: an investigation. Centre for Studies in Ethics and Rights, Mumbai, India, 2009. Available from: http://www.fairdrugs.org/uploads/files/Ethical_concerns_in_clinical_trials_in_India_An_investigation.pdf. Accessed in 2011 (Oct 11).

Iype G. Clinical trials: why India is irresistible. Available from: http://www.rediff.com/money/2004/dec/22spec.htm. Accessed in 2011 (Oct 28).

Hu Y, Huang Y, Ding J, et al. Status of clinical research in China. Lancet. 2011;377(9760):124-5.

Gevers W. Clinical research in South Africa: a core asset under pressure. Lancet. 2009;374(9692):760-2.

Siegfried N, Volmink J, Dhansay A. Does South Africa need a national clinical trials support unit? S Afr Med J. 2010;100(8):521-4.

Downloads

Published

2012-05-05

How to Cite

1.
Paula AP de, Giozza SP, Pereira MZ, Boaventura PS, Santos LMP, Sachetti CG, Tamayo COC, Kowalski CCG, Elias FTS, Serruya SJ, Guimarães R. Clinical investigations for SUS, the Brazilian public health system. Sao Paulo Med J [Internet]. 2012 May 5 [cited 2025 Mar. 9];130(3):179-86. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/1436

Issue

Vol. 130 No. 3 (2012)

Section

Short Communication

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.